These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 25343528
1. Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment. Ye Z, Wang C, Tang J, Zhou Y, Bai L, Liu Y, Kijlstra A, Yang P. J Interferon Cytokine Res; 2015 Apr; 35(4):265-72. PubMed ID: 25343528 [Abstract] [Full Text] [Related]
2. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease. Wang C, Tian Y, Lei B, Xiao X, Ye Z, Li F, Kijlstra A, Yang P. Invest Ophthalmol Vis Sci; 2012 Jul 10; 53(8):4668-75. PubMed ID: 22669715 [Abstract] [Full Text] [Related]
3. Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome. Liu X, Yang P, Lin X, Ren X, Zhou H, Huang X, Chi W, Kijlstra A, Chen L. Clin Immunol; 2009 May 10; 131(2):333-42. PubMed ID: 19200788 [Abstract] [Full Text] [Related]
5. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. Chi W, Yang P, Li B, Wu C, Jin H, Zhu X, Chen L, Zhou H, Huang X, Kijlstra A. J Allergy Clin Immunol; 2007 May 10; 119(5):1218-24. PubMed ID: 17335887 [Abstract] [Full Text] [Related]
6. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation. Bouali E, Kaabachi W, Hamzaoui A, Hamzaoui K. Immunol Lett; 2015 Oct 10; 167(2):87-94. PubMed ID: 26253248 [Abstract] [Full Text] [Related]
7. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease. Li F, Yang P, Liu X, Wang C, Hou S, Kijlstra A. Arch Ophthalmol; 2010 Nov 10; 128(11):1449-54. PubMed ID: 21060047 [Abstract] [Full Text] [Related]
9. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Chen L, Yang P, Zhou H, He H, Ren X, Chi W, Wang L, Kijlstra A. Invest Ophthalmol Vis Sci; 2008 Aug 10; 49(8):3475-82. PubMed ID: 18421089 [Abstract] [Full Text] [Related]
10. Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease. Peng Z, Jiang S, Wu M, Zhou X, Wang Q. Mol Vis; 2017 Aug 10; 23():538-547. PubMed ID: 28761327 [Abstract] [Full Text] [Related]
11. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome. Commodaro AG, Peron JP, Genre J, Arslanian C, Sanches L, Muccioli C, Rizzo LV, Belfort R. Scand J Immunol; 2010 Jul 10; 72(1):31-7. PubMed ID: 20591073 [Abstract] [Full Text] [Related]
12. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease. Sun M, Yang P, Du L, Yang Y, Ye J. PLoS One; 2014 Jul 10; 9(4):e93214. PubMed ID: 24690905 [Abstract] [Full Text] [Related]
13. Inhibitory effect of rapamycin and dexamethasone on production of IL-17 and IFN-gamma in Vogt-Koyanagi-Harada patients. Yang K, Wen J, Liu X, Kijlstra A, Chen L, Chi W, Zhou H, Huang X, Yang P. Br J Ophthalmol; 2009 Feb 10; 93(2):249-53. PubMed ID: 19019941 [Abstract] [Full Text] [Related]
14. Decreased interleukin(IL)-35 Expression is Associated with Active Intraocular Inflammation in Vogt-Koyanagi-Harada (VKH) Disease. Hu J, Qin Y, Yi S, Wang C, Yang J, Yang L, Wang L, Kijlstra A, Yang P, Li H. Ocul Immunol Inflamm; 2019 Feb 10; 27(4):595-601. PubMed ID: 29498905 [Abstract] [Full Text] [Related]
15. Increased IL-7 expression in Vogt-Koyanagi-Harada disease. Yang Y, Xiao X, Li F, Du L, Kijlstra A, Yang P. Invest Ophthalmol Vis Sci; 2012 Feb 27; 53(2):1012-7. PubMed ID: 22247488 [Abstract] [Full Text] [Related]
16. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease. Chu M, Yang P, Hu R, Hou S, Li F, Chen Y, Kijlstra A. Invest Ophthalmol Vis Sci; 2011 Sep 09; 52(10):7084-9. PubMed ID: 21810982 [Abstract] [Full Text] [Related]
17. [Expression of suppressor of cytokine signaling in peripheral blood monocular cells of patients with Vogt-Koyanagi-Harada disease]. Liu YX, Wang H, Peng XY, Zhou ZC. Zhonghua Yan Ke Za Zhi; 2009 Nov 09; 45(11):1015-9. PubMed ID: 20137421 [Abstract] [Full Text] [Related]
18. Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion. Liu L, Yang P, He H, Lin X, Jiang L, Chi W, Zhao C, Zhou H. Br J Ophthalmol; 2008 Apr 09; 92(4):557-61. PubMed ID: 18245271 [Abstract] [Full Text] [Related]
19. Increased Expression of IL-23 Receptor (IL-23R) in Vogt-Koyanagi-Harada (VKH) Disease. Wang C, Wang L, Hu J, Li H, Kijlstra A, Yang P. Curr Eye Res; 2018 Nov 09; 43(11):1369-1373. PubMed ID: 29877734 [Abstract] [Full Text] [Related]
20. p38{alpha} MAP kinase controls IL-17 synthesis in vogt-koyanagi-harada syndrome and experimental autoimmune uveitis. Commodaro AG, Bombardieri CR, Peron JP, Saito KC, Guedes PM, Hamassaki DE, Belfort RN, Rizzo LV, Belfort R, de Camargo MM. Invest Ophthalmol Vis Sci; 2010 Jul 09; 51(7):3567-74. PubMed ID: 20164464 [Abstract] [Full Text] [Related] Page: [Next] [New Search]